Effects of Respiratory Muscle Training in Individuals With Long-term Post-COVID-19 Symptoms
1 other identifier
interventional
64
1 country
1
Brief Summary
The main objective of the present study is to observe the short-term effects of respiratory muscle training combined with an exercise training program on quality of life and exercise tolerance in individuals with long-term post-COVID-19 symptoms. As secondary objectives, the effects on respiratory muscle function, physical and lung function, as well as on the psychological state of these individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable covid19
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2022
CompletedFirst Posted
Study publicly available on registry
October 28, 2022
CompletedStudy Start
First participant enrolled
October 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 22, 2023
CompletedSeptember 28, 2023
September 1, 2022
11 months
October 7, 2022
September 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in quality of life
Change in quality of life between baseline and post-intervention, as measured by the EuroQol-5D questionnaire which consists of 5 dimensions with 5 response options based on severity level, ranging from 1 to 5. An index score is provided, ranging from 0 (death) to 1 (full health).
Baseline and 1-week post-intervention (9 weeks from baseline)
Change in exercise tolerance
Change in exercise tolerance between baseline and post-intervention, as measured by a cardiopulmonary exercise test
Baseline and 1-week post-intervention (9 weeks from baseline)
Secondary Outcomes (4)
Change in respiratory muscle function
Baseline and 1-week post-intervention (9 weeks from baseline)
Change in physical function
Baseline and 1-week post-intervention (9 weeks from baseline)
Change in pulmonary function
Baseline and 1-week post-intervention (9 weeks from baseline)
Change in psychological status
Baseline and 1-week post-intervention (9 weeks from baseline)
Study Arms (2)
Exercise training + Inspiratory and expiratory muscle training group
EXPERIMENTALParticipants will perform a cardiovascular exercise program 2 days per week during 8 weeks in the hospital, combined with an inspiratory and expiratory muscle training by a threshold device at home, twice a day, 3 days per week, for 8 weeks supervised by a physiotherapist through a virtual platform.
Exercise training + Inspiratory and expiratory muscle training sham group
SHAM COMPARATORParticipants will perform a cardiovascular exercise program 2 days per week during 8 weeks in the hospital, combined with an inspiratory and expiratory muscle training by a sham threshold device at home, twice a day, 3 days per week, for 8 weeks supervised by a physiotherapist through a virtual platform.
Interventions
Participants will perform an inspiratory and expiratory muscle training including warm-up, recovery between intervals and return to calm.
Participants will perform an inspiratory and expiratory muscle training including warm-up, recovery between intervals and return to calm.
Participants will perform a cardiovascular exercise program including warm-up, recovery between intervals and return to calm by cycloergometer.
Eligibility Criteria
You may qualify if:
- Over 18 years who presented long-term post-COVID-19 symptoms of fatigue and dyspnoea for at least 3 months after the COVID-19 diagnosis
You may not qualify if:
- Progressive respiratory, neuromuscular or neurological disorders and/or psychiatric or cognitive conditions that hindered their ability to cooperate
- Comorbidity that could interfere with the study interventions
- Any contraindication to the training interventions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario 12 de Octubre de Madrid
Madrid, 28041, Spain
Related Publications (3)
McNarry MA, Berg RMG, Shelley J, Hudson J, Saynor ZL, Duckers J, Lewis K, Davies GA, Mackintosh KA. Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur Respir J. 2022 Oct 6;60(4):2103101. doi: 10.1183/13993003.03101-2021. Print 2022 Oct.
PMID: 35236727BACKGROUNDNopp S, Moik F, Klok FA, Gattinger D, Petrovic M, Vonbank K, Koczulla AR, Ay C, Zwick RH. Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Functional Status, Dyspnea, Fatigue, and Quality of Life. Respiration. 2022;101(6):593-601. doi: 10.1159/000522118. Epub 2022 Feb 24.
PMID: 35203084BACKGROUNDDel Corral T, Fabero-Garrido R, Plaza-Manzano G, Izquierdo-Garcia J, Lopez-Saez M, Garcia-Garcia R, Lopez-de-Uralde-Villanueva I. Effect of respiratory rehabilitation on quality of life in individuals with post-COVID-19 symptoms: A randomised controlled trial. Ann Phys Rehabil Med. 2025 Feb;68(1):101920. doi: 10.1016/j.rehab.2024.101920. Epub 2025 Jan 11.
PMID: 39798250DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ibai López de Uralde, PhD
Universidad Complutense de Madrid
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2022
First Posted
October 28, 2022
Study Start
October 28, 2022
Primary Completion
September 22, 2023
Study Completion
September 22, 2023
Last Updated
September 28, 2023
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share